NLRP3 and rheumatoid arthritis: The latest study shows that NLRP3 gene polymorphisms elevated the susceptibility to RA disease, and have an impact on RF as well as anti-CCP titers in RA patients, and pyroptosis will also be a possible therapeutic target for RA [41, 42].